about
Aspirin in the Chemoprevention of Colorectal Neoplasia: An OverviewAspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published StudiesBenefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetesDeveloping an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.Proinflammatory mediators and migraine pathogenesis: moving towards CGRP as a target for a novel therapeutic classCost-effectiveness of aspirin adjuvant therapy in early stage colorectal cancer in older patients.Fatal pulmonary embolism after arthroscopic rotator cuff repair: a case series.Moving the tipping point: the decision to anticoagulate patients with atrial fibrillationRecurrent hypertensive intracerebral haemorrhages: what should we do when a new hemispheric ischaemic event strikes?Aspirin for the prevention of colorectal cancerSystematic Review and Meta-Analysis of Randomised Trials to Ascertain Fatal Gastrointestinal Bleeding Events Attributable to Preventive Low-Dose Aspirin: No Evidence of Increased Risk.NSAID Use and Incident Cognitive Impairment in a Population-based Cohort.Recent changes in risk factors of chronic subdural hematomaIs Emtricitabine-Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection Safer Than Aspirin?Antiplatelet therapy in patients undergoing percutaneous coronary intervention: economic considerationsRisk of Stroke in Migraineurs Using Triptans. Associations with Age, Sex, Stroke Severity and Subtype.EMS management of acute stroke--out-of-hospital treatment and stroke system development (resource document to NAEMSP position statement).Mechanistic and pharmacological issues of aspirin as an anticancer agent.Stroke management in women.Gender differences in the primary prevention of stroke with aspirin.The role of low-dose aspirin in the prevention of colorectal cancer.Health maintenance in older adults: combining evidence and individual preferences.Aspirin resistance and other aspirin-related concerns.Incidence of intracranial bleeds in new users of low-dose aspirin: a cohort study using The Health Improvement Network.Cerebral Amyloid Angiopathy in Stroke Medicine.Chronic subdural hematoma: Surgical management and outcome in 986 cases: A classification and regression tree approach.Predictive Factors for Recurrence after Burr-Hole Craniostomy of Chronic Subdural Hematoma.Aspirin and intracerebral hemorrhage: Where are we now?Efficacy and Safety of Oral Diclofenac Sustained release Versus Transdermal Diclofenac Patch in Chronic Musculoskeletal Pain: A Randomized, Open Label Trial.Prophylactic Aspirin and Public.Tipping the Balance: Benefits and Risks of Aspirin in Chemoprevention of Colorectal Cancer
P2860
Q22306433-9E55A20D-63CE-4DC8-84EC-A58B448768AAQ26751511-040B3C23-E4BB-47D6-828F-FAE966FACC0CQ26853571-B84EAD5A-30B1-4679-8CA4-E7E4CFBDA195Q27321275-276B84CF-2BE3-432B-AFEB-0C123E442D85Q28292548-AD5E80C4-D266-4AEF-8B55-888F80AF1E04Q34251380-9D89F39D-9A8F-4365-9E85-83167DF83B9DQ34297528-A0D64C81-13B2-44BB-A765-BCA54498DE15Q34677974-BFA104B5-C768-4C5E-BFC3-C5EB0376EA27Q35034621-ACF0BEB9-A198-4C6F-8E84-03EE544EFEDCQ35967304-B6B00C64-0924-43F7-9606-097303E8C8B2Q36192713-9576675B-DCD0-42F3-8C5D-57495A13F0EAQ36348370-3B54BDE6-E60F-43EA-8FB0-35DF050D2E82Q36354109-D01C3FDB-A86F-4707-B6AC-F3222DC959A5Q36591180-E5EE55FA-C4C8-4961-A409-963930529358Q36754513-AC6D0615-2621-4F82-9CA0-D88DABAC8531Q36869870-9C249F38-0C07-4DC2-BEF2-2233B5EE11D9Q36871843-E6579D47-809D-45D7-8846-2E17DA46ED0AQ37277350-D7DDE375-CB07-4FFB-8049-BFABA70F50ABQ37608395-DC28D7F4-1D6C-455B-8DFA-C6358BACC451Q37879676-825CBF31-0670-4167-9DD7-7874E8256CAAQ37982139-8973EF79-3D72-4362-AD39-5F5116939655Q38043371-EF578EC4-B526-4917-A96C-8EFE135E658FQ38634815-83E48FE1-F4CF-4DE8-B0E0-F9C2D43131F0Q38858932-FD244B11-D724-4778-A0E2-98F9A66209F7Q39126853-CD1CB7BA-E610-4C8E-9398-83147EB76F2DQ40642249-E0C5373C-090B-4EB6-841E-6F6C8B3838BAQ47094081-8C3CA208-F742-40F5-A4BD-7F60F3BE6AC0Q49328817-31C86C51-28E4-4C69-A600-9AB6BAC5747DQ50154702-2E8F882E-C77D-4AFB-8E95-E9909817A2D3Q54682804-03191B69-658E-494C-9F38-4354242AF716Q58103818-53679224-F494-49E8-9236-1B9143C9032C
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Risk of hemorrhagic stroke with aspirin use: an update
@ast
Risk of hemorrhagic stroke with aspirin use: an update
@en
Risk of hemorrhagic stroke with aspirin use: an update
@nl
type
label
Risk of hemorrhagic stroke with aspirin use: an update
@ast
Risk of hemorrhagic stroke with aspirin use: an update
@en
Risk of hemorrhagic stroke with aspirin use: an update
@nl
prefLabel
Risk of hemorrhagic stroke with aspirin use: an update
@ast
Risk of hemorrhagic stroke with aspirin use: an update
@en
Risk of hemorrhagic stroke with aspirin use: an update
@nl
P3181
P1433
P1476
Risk of hemorrhagic stroke with aspirin use: an update
@en
P2093
Philip B Gorelick
Steven M Weisman
P304
P3181
P356
10.1161/01.STR.0000174189.81153.85
P407
P577
2005-08-01T00:00:00Z